Dysbindin and Schizophrenia: it's dopamine and glutamate all over again.
Dysbindin and Schizophrenia: it's dopamine and glutamate all over again.
复制标题
DOI:
10.1016/j.biopsych.2010.10.028
复制
发表时间:
2011-01-01
影响因子:
10.6
通讯作者:
Weinberger, Daniel R.
中科院分区:
文献类型:
--
作者:
Papaleo, Francesco;Weinberger, Daniel R.
Dysbindin-1 is encoded by the dystrobrevin-binding protein 1 gene (DTNBP1) and is located in synaptic sites throughout human and mouse brain (1). Genetic variations in DTNBP1 impact human cognitive abilities (2-3) and have been associated with risk for schizophrenia (4). Moreover, reduced dysbindin gene and protein expression have been reported in the hippocampus and prefrontal cortex (PFC) of schizophrenic patients (5-8). This latter finding suggests that a molecular phenotype associated with schizophrenia is reduced expression of dysbindin, perhaps of a specific isoform (8), but the role of secondary factors (eg drugs, smoking, etc.) and whether altered expression of any dysbindin transcript is the molecular mechanism of genetic risk have not been determined. These uncertainties notwithstanding, mutant mice with diminished DTNBP1 expression have become an informative animal model of reduced dysbindin protein (1, 5-8).While the statistical evidence for association of DTNBP1 and schizophrenia across diverse population samples is variable, the molecular evidence for a role of dysbindin in dopamine and glutamate signaling, two neurotransmitters at the core of neurochemical hypotheses of psychosis, is fairly consistent. Early speculation that the molecular mechanism of dysbindin's role in psychiatric illness had to do with the dystrophin protein complex, from which its name is derived, has been eclipsed by current data that implicate a pathogenic role of dysbindin as a partner in the biogenesis of lysosome-related organelles complex (BLOC-1). Dysbindin is involved in intracellular protein trafficking involving lysosomes and related organelles and it is important for synaptic homeostasis (1, 9). A number of receptor proteins, including D2 receptors and NR2A receptor subunits, are trafficked after internalization via lysosomal-mediated degradation and dysbindin has been shown to impact these trafficking events. Mice with disrupted dysbindin show selective alterations in internal trafficking of these specific components of dopamine and glutamate signaling, and not of other receptor components that are not trafficked through the lysosomal degradation pathway (eg D1 receptors, NR2B components [10-12]). Thus, dysbindin reductions may
登录
查看更多内容
DOI:
10.1111/j.1601-183x.2009.00477.x
发表时间:
2009-06
期刊:
Genes, brain, and behavior
影响因子:
--
作者:
Cox MM;Tucker AM;Tang J;Talbot K;Richer DC;Yeh L;Arnold SE
通讯作者:
Arnold SE
DOI:
10.1038/npp.2009.90
发表时间:
2009-11
期刊:
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology
影响因子:
--
作者:
通讯作者:
--
影响因子:
4.5
作者:
Weickert, Cynthia Shannon;Rothmond, Debora A.;Straub, Richard E.
通讯作者:
Straub, Richard E.
DOI:
10.1126/science.1179685
发表时间:
2009-11-20
期刊:
Science (New York, N.Y.)
影响因子:
--
作者:
Dickman DK;Davis GW
通讯作者:
Davis GW
影响因子:
3.5
作者:
Burdick, KE;Lencz, T;Malhotra, AK
通讯作者:
Malhotra, AK